COVID-19 booster triggers severe immune response in man with SM
A patient with systemic mastocytosis suffered a life-threatening immune reaction after receiving an mRNA-1273 COVID-19 booster.
A patient with systemic mastocytosis suffered a life-threatening immune reaction after receiving an mRNA-1273 COVID-19 booster.
A patient who was diagnosed with mast cell leukemia, a rare form of SM, experienced symptom relief with methylprednisolone treatment.
A genetic trait that increases risk of anaphylaxis is higher in people with SM. Identifying the trait early could mean better treatment.
A rare case of systemic mastocytosis (SM) manifesting as generalized seizures was recently described in a case report.
A 9-year-old girl underwent a stem cell transplant after being diagnosed with SM following treatment for a germ cell tumor.
The targeted therapy drug gemtuzumab ozogamicin successfully treated a young boy with SM-AHN who did not respond to conventional therapies.
A case report describes a patient who experienced two failed transcatheter aortic valve replacements, likely related to her underlying SM.
A man with systemic mastocytosis experienced a severe allergic reaction and eventually died after being stung by a wasp.
Duplex sequencing can reveal KIT mutations in a subset of patients with SM who do not have detectable mutations by ddPCR, a study found.
Results from a recent study could support more accurate diagnosis and future therapies in indolent systemic mastocytosis.